AML represents a group of diverse bone marrow disorders in which immature bone marrow cells,
 known as blast cells, accumulate in the bone marrow. In AML, these blast cells belong to the family
 of bone marrow cells which make red blood cells, platelets, and infection-fighting white blood cells
 (neutrophils and monocytes). Because of this accumulation of blast cells, production of normal bone
 marrow and blood cells is diminished. Patients can experience severe anemia as well as low platelet
 counts which can put patients at risk of life-threatening bleeding. Patients with untreated AML may
 develop serious infections because of reduced numbers of infection-fighting cells known as
 neutrophils. Left untreated, AML can be a rapidly fatal disease.Fortunately, AML can be brought into remission in approximately 70% of cases using intensive chemotherapy, and can be cured in many cases, using chemotherapy or bone marrow transplantation. Click here for more detailed information about AML.